Evidence map›Paper›PMID 31270077›Full record

ArticleCancer research2019

Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death.

Lia Tesfay, Bibbin T Paul, Anna Konstorum, Zhiyong Deng, Anderson O Cox, Jingyun Lee, Cristina M Furdui, Poornima Hegde, Frank M Torti, Suzy V Torti

Abstract readComment
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 356 papers.

0numbers the graph read from it
0cells of the map it votes in
356citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

356 citing papers in PubMed, 537 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Ferroptosis: The Demise of Cells Through Phospholipid Peroxidation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review

296 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lia TesfayDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, Connecticut.
Bibbin T PaulDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, Connecticut.
Anna KonstorumCenter for Quantitative Medicine, UConn Health, Farmington, Connecticut.ORCID 0000-0003-4024-2058
Zhiyong DengDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, Connecticut.
Anderson O CoxProteomics and Metabolomics Shared Resource, Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Jingyun LeeProteomics and Metabolomics Shared Resource, Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Cristina M FurduiProteomics and Metabolomics Shared Resource, Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Poornima HegdeDepartment of Pathology, UConn Health, Farmington, Connecticut.
Frank M TortiDepartment of Medicine, UConn Health, Farmington, Connecticut.
Suzy V TortiDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, Connecticut. storti@uchc.edu.
UConn Health · USWake Forest University · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Iron, Ferroptosis and Ovarian CancerR01CA188025 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI TORTI, SUZY V · 2014 to 2024
$3.9M
Ferroportin and Iron HomeostasisR01CA171101 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI TORTI, FRANK M. · 2012 to 2016
$1.7M
Multiscale modeling of synergistic T cell activation for cancer immunotherapyF32CA214030 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KONSTORUM, ANNA · 2017 to 2018
$116k
NCI NIH HHS F32 CA214030NCI NIH HHS P30 CA012197NCI NIH HHS R01 CA171101NCI NIH HHS R01 CA188025
6 · The paper itself

Abstract

Activation of ferroptosis, a recently described mechanism of regulated cell death, dramatically inhibits growth of ovarian cancer cells. Given the importance of lipid metabolism in ferroptosis and the key role of lipids in ovarian cancer, we examined the contribution to ferroptosis of stearoyl-CoA desaturase (SCD1,

Indexed as

Ovarian NeoplasmsStearoyl-CoA DesaturaseAnimalsApoptosisCell DeathFemaleFerroptosisHumansMiceStearoyl-CoA Desaturase

Identifiers

PMID31270077
PMCPMC6801059
OpenAlexW2953615255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.